Articles
Vol. 3 No. 1 (2025)

Oral Ialoral® Forte versus ultrasound-guided intra-articular cortisone infiltration: results of a retrospective single-center study

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 1 December 2025
14
Views
5
Downloads

Authors

Osteoarthritis (OA) is a common cause of pain and functional limitation. We compared the analgesic and functional outcomes of Ialoral® Forte, a nutraceutical formulation, with those of ultrasound-guided intra-articular triamcinolone in patients with hip or knee OA and baseline Numeric Rating Scale (NRS) ≤5. This retrospective single-center study included 60 patients (NRS≤5, Kellgren-Lawrence grade I-II) treated between June 2022 and January 2023. Group A received oral Ialoral® Forte (two tablets daily for 40 days); group B underwent two ultrasound-guided intraarticular corticosteroid injections 20 days apart. Pain intensity (NRS) and joint function (Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC]) were evaluated at baseline and at 20, 40, 60, and 90 days. Both treatments significantly reduced pain and improved joint function over time. No statistically significant differences were observed between groups (p>0.05). Oral Ialoral® Forte achieved comparable analgesic and functional outcomes to intra-articular corticosteroids, without injection-related risks or contraindications. Oral Ialoral® Forte represents a safe, effective, and non-invasive alternative to intra-articular corticosteroid injections for the management of mild to moderate osteoarthritis, providing similar short-term pain relief and functional recovery with excellent tolerability.

Downloads

Download data is not yet available.

Citations

1. Hawker GA. Osteoarthritis: a serious disease [Internet]. Osteoarthritis Research Society International; 2016. Available from: https://www.oarsi.org/research/oa-serious-disease
2. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743-800.
3. Losina E, Weinstein AM, Reichmann WM, et al. Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res (Hoboken) 2013;65:703-11. DOI: https://doi.org/10.1002/acr.21898
4. Srikanth VK, Fryer JL, Zhai G, et al. A meta-analysis of sex differences in prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage 2005;13:769-81. DOI: https://doi.org/10.1016/j.joca.2005.04.014
5. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA 2021;325:568-78. DOI: https://doi.org/10.1001/jama.2020.22171
6. Kohn MD, Sassoon AA, Fernando ND. Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clin Orthop Relat Res 2016;474:1886-93. DOI: https://doi.org/10.1007/s11999-016-4732-4
7. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502. DOI: https://doi.org/10.1136/ard.16.4.494
8. Messier SP, Mihalko SL, Legault C, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA 2013;310:1263-73. DOI: https://doi.org/10.1001/jama.2013.277669
9. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019;27:1578-89. DOI: https://doi.org/10.1016/j.joca.2019.06.011
10. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 2020;72:220-33. DOI: https://doi.org/10.1002/art.41142
11. Webner D, Huang Y, Hummer CD 3rd. Intraarticular hyaluronic acid preparations for knee osteoarthritis: are some better than others? Cartilage 2021;13:1619S-36S. DOI: https://doi.org/10.1177/19476035211017320
12. Joergensen A, Stengaard-Pedersen K, Simonsen O, et al. Intraarticular hyaluronan is without clinical effect in knee osteoarthritis: a multicenter, randomized, placebo-controlled, double-blind study of 337 patients followed for one year. Ann Rheum Dis 2010;69:1097-102. DOI: https://doi.org/10.1136/ard.2009.118042
13. Cheng OT, Souzdalnitski D, Vrooman B, Cheng J. Evidence-based knee injections for the management of arthritis. Pain Med 2012;13:740-53. DOI: https://doi.org/10.1111/j.1526-4637.2012.01394.x
14. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59:936-44. DOI: https://doi.org/10.1136/ard.59.12.936
15. McAlindon TE, LaValley MP, Harvey WF, et al. Effect of intraarticular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA 2017;317:1967-75. DOI: https://doi.org/10.1001/jama.2017.5283
16. Conaghan PG, Hunter DJ, Cohen SB, et al. Effects of a single intra-articular injection of a microsphere formulation of triamcinolone acetonide on knee osteoarthritis pain: a randomized, placebo-controlled, multinational study. J Bone Joint Surg Am 2018;100:666-77. DOI: https://doi.org/10.2106/JBJS.17.00154
17. Zeng C, Lane NE, Hunter DJ, et al. Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2019;27:855-62. DOI: https://doi.org/10.1016/j.joca.2019.01.007
18. Schauss AG, Stenehjem J, Park J, et al. Effect of the novel low molecular weight hydrolyzed chicken sternal cartilage extract, BioCell Collagen, on improving osteoarthritis-related symptoms: a randomized, double-blind, placebo-controlled trial. J Agric Food Chem 2012;60:4096-101. DOI: https://doi.org/10.1021/jf205295u
19. Bello AE, Oesser S. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr Med Res Opin 2006;22:2221-32. DOI: https://doi.org/10.1185/030079906X148373
20. Varilla C, Marcone M, Paiva L, Baptista J. Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary. Foods 2021;10:2249. DOI: https://doi.org/10.3390/foods10102249
21. Rahme E, Bernatsky S. NSAIDs and risk of lower gastrointestinal bleeding. Lancet 2010;376:146-8. DOI: https://doi.org/10.1016/S0140-6736(10)60839-2
22. Hochberg MC, Wohlreich M, Gaynor P, et al. Clinically relevant outcomes based on analysis of pooled data from two trials of duloxetine in patients with knee osteoarthritis. J Rheumatol 2012;39:352-8. DOI: https://doi.org/10.3899/jrheum.110307
23. Osani MC, Bannuru RR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Korean J Intern Med 2019;34:966-73. DOI: https://doi.org/10.3904/kjim.2018.460

How to Cite



Oral Ialoral® Forte versus ultrasound-guided intra-articular cortisone infiltration: results of a retrospective single-center study. (2025). Advances in Anesthesia and Pain Medicine, 3(1). https://doi.org/10.4081/aapm.59